Cargando…
The Prevalence of High-Risk Human Papillomavirus in Hungary—A Geographically Representative, Cross-Sectional Study
Background: The estimated age-standardized incidence and mortality rates of cervical cancer in Hungary are substantially higher than the European average. In many countries, human papillomavirus (HPV) testing is the first-line method of cervical cancer screening in women >30 years. According to t...
Autores principales: | Fogarasi, András István, Benczik, Márta, Moravcsik-Kornyicki, Ágota, Kocsis, Adrienn, Gyulai, Anikó, Kósa, Zsigmond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240187/ https://www.ncbi.nlm.nih.gov/pubmed/35783359 http://dx.doi.org/10.3389/pore.2022.1610424 |
Ejemplares similares
-
Comparison of Cancer Survival Trends in Hungary in the Periods 2001–2005 and 2011–2015 According to a Population-Based Cancer Registry
por: Kenessey, István, et al.
Publicado: (2022) -
Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary
por: Müller, Judit, et al.
Publicado: (2022) -
A Study of Prognostic Factors in Young Patients With Non-HPV Oral Cancer in Central Europe
por: Csurgay, Katalin, et al.
Publicado: (2021) -
Patient delay and its clinical significance among head and neck cancer patients in Hungary
por: Dános, Kornél, et al.
Publicado: (2023) -
Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
por: Gálffy, Gabriella, et al.
Publicado: (2021)